ST Renfu Says Drug for Adult Schizophrenia to Be Produced Based on Market Demand

ST Renfu has issued a company announcement regarding a drug intended for the treatment of adult schizophrenia. The announcement states that the drug is mainly used for this indication. The company will arrange the production and market introduction of the related product according to market demand. No further information was provided in the announcement, including the drug's name or any specific timing for production and launch. The statement was made public in a corporate notice.